156 related articles for article (PubMed ID: 16134185)
1. In vivo real-time diagnosis of nasopharyngeal carcinoma in situ by contact rhinoscopy.
Wai Pak M; To KF; Lee JC; Liang EY; van Hasselt CA
Head Neck; 2005 Nov; 27(11):1008-13. PubMed ID: 16134185
[TBL] [Abstract][Full Text] [Related]
2. Nasopharyngeal carcinoma in situ (NPCIS)--pathologic and clinical perspectives.
Pak MW; To KF; Lo YM; Chan LY; Tong JH; Lo KW; van Hasselt CA
Head Neck; 2002 Nov; 24(11):989-95. PubMed ID: 12410533
[TBL] [Abstract][Full Text] [Related]
3. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.
Pathmanathan R; Prasad U; Sadler R; Flynn K; Raab-Traub N
N Engl J Med; 1995 Sep; 333(11):693-8. PubMed ID: 7637746
[TBL] [Abstract][Full Text] [Related]
4. Nasopharyngeal carcinoma in situ: two cases of an emerging diagnostic entity.
Cheung F; Pang SW; Hioe F; Cheung KN; Lee A; Yau TK
Cancer; 1998 Sep; 83(6):1069-73. PubMed ID: 9740069
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma.
Tsai ST; Jin YT; Mann RB; Ambinder RF
Cancer; 1998 Apr; 82(8):1449-53. PubMed ID: 9554519
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
7. In vivo diagnosis of nasopharyngeal carcinoma using contact rhinoscopy.
Pak MW; To KF; Leung SF; van Hasselt CA
Laryngoscope; 2001 Aug; 111(8):1453-8. PubMed ID: 11568583
[TBL] [Abstract][Full Text] [Related]
8. In vivo diagnosis of persistent and recurrent nasopharyngeal carcinoma by contact endoscopy.
Pak MW; To KF; Leung SF; van Hasselt CA
Laryngoscope; 2002 Aug; 112(8 Pt 1):1459-66. PubMed ID: 12172263
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
11. EBER in situ hybridization differentiates carcinomas originating from the sinonasal region and the nasopharynx.
Hwang TZ; Jin YT; Tsai ST
Anticancer Res; 1998; 18(6B):4581-4. PubMed ID: 9891522
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Epstein-Barr virus DNA in cell-free plasma, functional imaging and clinical course in locally advanced nasopharyngeal cancer: a pilot study.
Mäkitie AA; Reis PP; Irish J; Zhang T; Chin SF; Chen X; Marriott C; Keller A; Perez-Ordonez B; Kamel-Reid S; Siu LL
Head Neck; 2004 Sep; 26(9):815-22. PubMed ID: 15350028
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal intraepithelial lesion: latent Epstein-Barr virus infection with malignant potential.
Cheung FM; Pang SW; Yau TK; Chow SK; Lo KW
Histopathology; 2004 Aug; 45(2):171-9. PubMed ID: 15279636
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842
[TBL] [Abstract][Full Text] [Related]
15. Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.
Kalpoe JS; Dekker PB; van Krieken JH; Baatenburg de Jong RJ; Kroes AC
J Clin Pathol; 2006 May; 59(5):537-41. PubMed ID: 16489178
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein-Barr virus DNA.
Hong RL; Lin CY; Ting LL; Ko JY; Hsu MM
Cancer; 2004 Apr; 100(7):1429-37. PubMed ID: 15042677
[TBL] [Abstract][Full Text] [Related]
17. How reliable is contact endoscopy of the nasopharynx in patients with nasopharyngeal cancer?
Pak MW; Vlantis AC; Chow S; van Hasselt CA
Laryngoscope; 2009 Mar; 119(3):523-7. PubMed ID: 19235751
[TBL] [Abstract][Full Text] [Related]
18. Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization.
Mirzamani N; Salehian P; Farhadi M; Tehran EA
Exp Mol Pathol; 2006 Dec; 81(3):231-4. PubMed ID: 16787643
[TBL] [Abstract][Full Text] [Related]
19. Localization of Epstein-Barr virus in lymph node metastasis with nasopharyngeal carcinoma.
Akao I; Sato Y; Mukai K; Sugano S; Hoshikawa T; Suzuki T; Tsutsumi K
Acta Otolaryngol Suppl; 1996; 522():86-8. PubMed ID: 8740817
[TBL] [Abstract][Full Text] [Related]
20. Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.
Lin JC; Wang WY; Liang WM; Chou HY; Jan JS; Jiang RS; Wang JY; Twu CW; Liang KL; Chao J; Shen WC
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1342-8. PubMed ID: 17449194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
